Robert Schier – Startup Investor Profile

Robert Schier is a Senior Investment Director at Zürcher Kantonalbank Asset Management (Swisscanto Private Equity) with a background in pharmacy and biotechnology. He has significant experience in investing in healthcare and life sciences sectors, managing investments in private start-ups, and serving on the boards of numerous life sciences companies. Robert’s investment focus areas include healthcare and life sciences. He has been involved in investments in over 20 start-ups and 25 companies as part of an investment committee. His check sizes for investments range from CHF 8 million to CHF 16 million. Dr. Schier is known for his hands-on partnership and collaboration styles, bringing expertise and strategic insights to his portfolio companies.

Location:

Country: Switzerland

Investment Regions: EU

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Searches of Swisscanto team page, Medimaps profile and LinkedIn references confirm Robert Schier is Senior Investment Director at Zürcher Kantonalbank (Swisscanto Private Equity) and has been involved historically with many life-science investments, including a public LinkedIn post mentioning Medimaps. However, I found no verifiable public record of a specific investment by Robert Schier with a date within the last several years (no named startup with a dated transaction in 2024-2025). Therefore there is insufficient evidence to determine recent activity; using the default ‘not-found’. The startup mentioned in available sources is Medimaps (LinkedIn post).

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.